Raily Aesthetic Medicine International Holdings (HKSE:02135) Debt-to-Equity : 0.32 (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Raily Aesthetic Medicine International Holdings Debt-to-Equity?

Raily Aesthetic Medicine International Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$21.8 Mil. Raily Aesthetic Medicine International Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$35.5 Mil. Raily Aesthetic Medicine International Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2023 was HK$182.0 Mil. Raily Aesthetic Medicine International Holdings's debt to equity for the quarter that ended in Jun. 2023 was 0.31.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Raily Aesthetic Medicine International Holdings's Debt-to-Equity or its related term are showing as below:

HKSE:02135' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.17 Med: 0.34 Max: 1.81
Current: 0.38

During the past 7 years, the highest Debt-to-Equity Ratio of Raily Aesthetic Medicine International Holdings was 1.81. The lowest was 0.17. And the median was 0.34.

HKSE:02135's Debt-to-Equity is ranked better than
55.74% of 549 companies
in the Healthcare Providers & Services industry
Industry Median: 0.48 vs HKSE:02135: 0.38

Raily Aesthetic Medicine International Holdings Debt-to-Equity Historical Data

The historical data trend for Raily Aesthetic Medicine International Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raily Aesthetic Medicine International Holdings Debt-to-Equity Chart

Raily Aesthetic Medicine International Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.36

0.17

0.38

0.29

0.38

Raily Aesthetic Medicine International Holdings Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial							0.38	0.27	0.29	0.32	0.38

Competitive Comparison of Raily Aesthetic Medicine International Holdings's Debt-to-Equity

For the Medical Care Facilities subindustry, Raily Aesthetic Medicine International Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raily Aesthetic Medicine International Holdings's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raily Aesthetic Medicine International Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Raily Aesthetic Medicine International Holdings's Debt-to-Equity falls into.

Raily Aesthetic Medicine International Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Raily Aesthetic Medicine International Holdings's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(15.261	+	38.588)	/	185.464
	=	0.29

Raily Aesthetic Medicine International Holdings's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(21.798	+	35.511)	/	181.996
	=	0.31

Raily Aesthetic Medicine International Holdings (HKSE:02135) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Raily Aesthetic Medicine International Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Raily Aesthetic Medicine International Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Raily Aesthetic Medicine International Holdings (HKSE:02135) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raily Aesthetic Medicine International Holdings Ltd (HKSE:02135) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN

Website

http://m.raily.com

Raily Aesthetic Medicine International Holdings Ltd is an aesthetic medical service provider in Zhejiang Province, the PRC. It offers a broad range of aesthetic medical services to clients to meet their different aesthetic and anti-aging objectives. The group is organized into business units based on their services and has three reportable operating segments namely Aesthetic medical services which comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology services, and others; and Consulting service segment which comprise principally management consulting services. Aesthetic medical equipment products comprise principally sales of surgical implants and aesthetic medical skincare products.

Executives

Fu Haishu	2201 Interest of corporation controlled by you
Jin Chunmiao	2202 Interest of your spouse
Ruide Consultation Limited	2101 Beneficial owner
Youxin Management Co., Limited	2101 Beneficial owner
Beauty Milkway (hk) Limited
China Orient Asset Management (international) Holding Limited
China Orient Asset Management Co., Ltd.
Dong Yin Development (holdings) Limited
Wise Leader Assets Ltd.
Shang Hai Dong Hua Jian Kang Guan Li He Huo Qi Ye You Xian He Huo
Dong Fang Zi Chan Guan Li Zhong Guo Kong Gu You Xian Gong Si
Shen Zhen Dong Fang Chuang Ye Tou Zi You Xian Gong Si
Shen Zhen Qian Hai Cai Fu Dong Fang Gu Quan Tou Zi Ji Jin Guan Li You Xian Gong Si
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Fa Zhan Ji Jin You Xian He Huo
Qing Hai Sheng Dong Fang Cang Yi Yao Chan Ye Tou Zi Guan Li You Xian Gong Si

Raily Aesthetic Medicine International Holdings (HKSE:02135) Headlines

No Headlines